A serum miRNA classifier diagnoses bone and soft tissue sarcomas across various histological subtypes

A serum miRNA combination could be a powerful classifier for the detection of patients with bone and soft tissue sarcomas. Total 892 patients with bone and soft tissue tumors, including malignant, intermediate, and benign tumors, were included. Furthermore, serum samples of 275 healthy controls and 240 patients with other cancers were used as references for the analyses.